RPG Life Sciences Q2 FY10 PBT up by 7%

• Revenue  of Rs. 41.95 crores as against Rs. 41.89 crores
• Net profit at Rs 3.74 crores as against Rs. 3.49  crores

RPG Life Sciences Ltd.,an RPG group company, today announced its unaudited results for quarter ended 30th September 2009.

The company’s net sales were Rs. 41.43 crores as against Rs 40.88 crores for the corresponding quarter last year. PBT grew by 7 % to Rs. 3.74 crores from Rs. 3.49 crores in corresponding quarter last year.

“The Contribution margin has increased by 3.4 % as compared to corresponding quarter last year mainly due to better product mix sales and lower input cost and we are confident of keeping the momentum in the year ahead,” commented Mr. Arvind Vasudeva, MD of the company.

About RPG Life Sciences Ltd
RPG Life Sciences Ltd. is an important player in Formulations, Bulk Drugs and Biotech business. The company is present in the domestic as well as the international markets. It exports its products primarily to Europe, Latin America, Africa, Canada & South East Asian countries.  . RPG Life Sciences is the flagship company in the pharma sector of the RPG Group.

About RPG Enterprises
RPG Enterprises is one of the India’s leading business groups with a turnover of Rs 15,000 crores. RPG Enterprises has presence in Sectors like Power, Tyres, Retail, IT, Transmission, Carbon Black, Specialty & Entertainment.